StonvexLoading…
StonvexStonvexStonvexCore line items from AEVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $18.08M | $9.06M | $4.31M | $4.19M |
Operating Income | $-127.60M | $-158.37M | $-147.79M | $-151.96M |
Net Income | $-145.43M | $-152.26M | $-149.33M | $-147.31M |
EPS (Diluted) | $-2.55 | $-2.85 | $-3.29 | $-3.39 |
Total Assets | $179.70M | $147.49M | $257.38M | $356.63M |
Total Liabilities | $166.49M | $48.14M | $28.94M | $26.71M |
Cash & Equivalents | $72.29M | $28.86M | $38.55M | $67.42M |
Free Cash Flow OCF − CapEx | $-119.69M | $-112.02M | $-124.93M | $-117.35M |
Shares Outstanding | 61.58M | 54.14M | 52.39M | 218.75M |